immune thrombocytopenic purpura


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia, Wikipedia.

id·i·o·path·ic throm·bo·cy·to·pe·nic pur·pu·ra (ITP),

a systemic illness characterized by extensive ecchymoses and hemorrhages from mucous membranes and very low platelet counts; resulting from platelet destruction by macrophages due to an antiplatelet factor; childhood cases are usually brief and rarely present with intracranial hemorrhages, but adult cases are often recurrent and have a higher incidence of grave bleeding, especially intracranial.

immune thrombocytopenic purpura

Idiopathic thrombocytopenic purpura, see there.

id·i·o·path·ic throm·bo·cy·to·pe·nic pur·pu·ra

(ITP) (id'ē-ō-path'ik throm'bō-sī-tō-pē'nik pŭr'pyŭr-ă)
A systemic illness characterized by extensive ecchymoses and hemorrhages from mucous membranes and very low platelet counts; resulting from destruction in the spleen of platelets to which an autoimmune globulin is bound; childhood cases, which often follow viral infection, are mild and transitory; in adults, bleeding may be recurrent and severe.
Synonym(s): immune thrombocytopenic purpura, purpura hemorrhagica, thrombopenic purpura.
References in periodicals archive ?
The Risk of Immune Thrombocytopenic Purpura After Vaccination in Children and Adolescents.
Coalson et al., "Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database," British Journal of Haematology, vol.
Immune thrombocytopenic purpura responds rapidly to prednisolone treatment.
Immune thrombocytopenic purpura: The changing therapeutic landscape.
Immune thrombocytopenic purpura is the most common reason of acquired thrombocytopenia in the pediatric age group (1).
Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials.
Coronary artery bypass grafting in an immune thrombocytopenic purpura patient using off-pump techniques.
Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.
Thank you for your cover story on NYCB principal Janie Taylor (July) and her battle with immune thrombocytopenic purpura (ITP).
Safety and efficacy of low-dose intravenous immune globulin treatment for infants and children with immune thrombocytopenic purpura. Low-Dose IVIG Study Group.
The condition, which usually develops in adults, is known as chronic immune thrombocytopenic purpura (ITP), a disease that results in a low number of platelets, the blood components that help with clotting.
has announced that the FDA has approved Nplate(TM) (romiplostim), the first and only platelet producer for the treatment of thrombocytopenia in splenectomized (spleen removed) and non-splenectomized adults with chronic immune thrombocytopenic purpura (ITP).